(Q72672964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Patrizia Boracchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

author name string

G Gasparini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

W J Gullick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Maluta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P Dalla Palma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

E Leonardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

F Pozza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

N R Lemoine

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P Bevilacqua

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

30A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

16-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

The type 1 (EGFR-related) family of growth factor receptors and their ligands

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

The HER-2/neu oncogene in breast cancer: so what is new?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Expression of the ERBB3 gene product in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Immunocytochemical detection of progesterone receptor by monoclonal KD-68 antibody in operable breast cancer: correlations with biochemical assay, pathological features and cell proliferative rate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Expression of the c-erbB-2 protein in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Tumor grade as a prognostic factor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980010-3

7 January 2021

10.1016/S0959-8049(05)80010-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7908213%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference